Molecular Pharmacology and Pathology Program, Department of Pathology, University of Sydney, Australia.
Department of Medicinal Chemistry & Pharmacognosy, University of Illinois at Chicago, Chicago, IL 60612, USA.
Nitric Oxide. 2018 Jun 1;76:37-44. doi: 10.1016/j.niox.2018.03.003. Epub 2018 Mar 6.
The chelatable iron pool (CIP) is a small but chemically significant fraction of total cellular iron. While this dynamic population of iron is limited, it is redox active and capable of generating reactive oxygen species (ROS) that can lead to oxidative stress which is associated with various pathologies. Nitric oxide (•NO), is a free radical signalling molecule that regulates numerous physiological and pathological conditions. We have previously shown that macrophages exposed to endogenously generated or exogenously administered nitric oxide (•NO) results in its interaction with CIP to form dinitrosyliron complexes with thiol containing ligands (DNICs). In this study we assessed the consequences of DNIC formation in cancer cells as •NO is known to be associated with numerous malignancies. Incubation of cancer cells with •NO led to a time and dose dependent increase in formation of DNICs. The formation of DNICs results in the sequestration of the CIP which is a major source of iron for redox reactions and reactive oxygen species (ROS) generation. Therefore, we set out to test the antioxidant effect of •NO by measuring the ability of DNICs to protect cells against oxidative stress. We observed that cancer cells treated with •NO were partially protected against HO mediated cytotoxicity. This correlated to a concomitant decrease in the formation of oxidants when •NO was present during HO treatment. Similar protective effects were achieved by treating cells with iron chelators in the presence of HO. Interestingly, •NO decreased the rate of cellular metabolism of HO suggesting that a proportion of HO is consumed via reactions with cellular iron. When the CIP was artificially increased by supplementation of cells with iron, a significant decrease in the cytoprotective effect of •NO was observed. Notably, •NO concentrations, at which cytoprotective and antioxidant effects were observed, correlated with concentration-dependent increases in DNIC formation. Collectively, these results demonstrate that •NO has antioxidant properties by its ability to sequester cellular iron. This could play a significant role in variety of diseases involving ROS mediated toxicity like cancer and neurodegenerative disorders where •NO has been shown to be an important etiologic factor.
可螯合铁池(CIP)是细胞总铁量中很小但具有重要化学意义的一部分。虽然这个动态的铁池有限,但它具有氧化还原活性,能够生成活性氧物种(ROS),导致氧化应激,与各种病理有关。一氧化氮(•NO)是一种自由基信号分子,调节许多生理和病理条件。我们之前已经表明,巨噬细胞暴露于内源性产生或外源性给予的一氧化氮(•NO)会导致其与 CIP 相互作用,形成含有硫醇配体的二硝酰基铁复合物(DNICs)。在这项研究中,我们评估了 DNIC 形成在癌细胞中的后果,因为已知•NO 与许多恶性肿瘤有关。癌细胞与•NO 孵育会导致 DNIC 形成的时间和剂量依赖性增加。DNIC 的形成导致 CIP 的隔离,CIP 是氧化还原反应和活性氧物种(ROS)生成的主要铁源。因此,我们着手通过测量 DNIC 保护细胞免受氧化应激的能力来测试•NO 的抗氧化作用。我们观察到,用•NO 处理的癌细胞对 HO 介导的细胞毒性有一定的保护作用。这与 HO 处理时存在•NO 时氧化剂形成的同时减少相关。在用 HO 处理细胞时,用铁螯合剂处理细胞也能达到类似的保护效果。有趣的是,•NO 降低了 HO 对细胞代谢的速率,这表明一部分 HO 通过与细胞铁的反应而被消耗。当通过向细胞中补充铁来人为地增加 CIP 时,观察到•NO 的细胞保护作用显著降低。值得注意的是,观察到细胞保护和抗氧化作用的•NO 浓度与 DNIC 形成的浓度依赖性增加相关。总的来说,这些结果表明,•NO 通过螯合细胞铁具有抗氧化特性。这在涉及 ROS 介导的毒性的各种疾病中可能起着重要作用,如癌症和神经退行性疾病,其中已经表明•NO 是一个重要的病因因素。